Skip to NavigationSkip to content

Pharmafile - Medical Communications News

For those looking to accelerate their renewable energy goals, Power Purchase Agreements (PPA) are a viable option and will help pharma businesses...
The Pfizer/BioNTech vaccine continues to lead the pack, having been approved for emergency use in the UK earlier this week. However, experts have...
Spravato, in combination with comprehensive standard of care, led to a “statistically significant and clinically meaningful reduction in depressive...
Data from the Phase 1/2 study showed that the two-dose vaccine generated comparable levels of neutralising antibody titers to those seen in...
The US saw its highest daily death toll from the virus on Wednesday, with over 3,000 deaths recorded – more US deaths in a 24-hour period than in...
While Aimovig costs around £5,000 per patient per year, the NHS has agreed with Novartis to access the drug at a confidential discounted price....
Vaccinations began this week in the UK with Pfizer and BioNTech's candidate after it secured emergency approval. However, despite the good news,...
As the year winds to a close, excitement is rising around the efficacy and availability of COVID-19 vaccines around the world as global regulators...
Hospitalised female COVID-19 patients who had fulfilled a 90-day prescription for metformin were associated with a 21-24% reduction in the risk of...
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches